Logo

American Heart Association

  2
  0


Final ID: MDP1166

Effectively Communicating the Seriousness of High Cholesterol at Diagnosis to Improve Shared Decision-Making and Adherence: Findings from the Patient-Led “Insights from Patients Living with Elevated Cholesterol” (IPEC) Study

Abstract Body (Do not enter title and authors here): Background: Shared decision-making aims to improve health outcomes by empowering patients to make informed decisions with their healthcare providers. While decision aids guide treatment choices, they may not help providers effectively communicate the importance of treatment and the risks of non-adherence. We explored patient perspectives on shared decision-making and communication of CVD risks upon diagnosis with elevated LDL-C, a significant risk factor for CVD.

Aims: To learn from people with high cholesterol about their experiences, decisions, and perspectives on being diagnosed and living with high LDL-C, including awareness of the association between high LDL-C and other risk factors for heart disease and stroke.

Methods: The design and interpretation of this cross-sectional, qualitative study were guided by a global multi-disciplinary steering committee. Fifty people with confirmed high LDL-C in Brazil, Australia, and the United States participated in 60-minute interviews between November 2023-March 2024. Half were required to have an ASCVD-related hospitalization. Interview transcripts were thematically analyzed.

Results: Table 1 describes participant characteristics. During their high-LDL-C diagnosis encounter, participants often described being overwhelmed by multiple concurrent diagnoses, unfamiliar medical terms, and concerns about elevated cardiac risk. Most participants stated that their primary source of information, upon diagnosis and throughout their experiences with high LDL-C, is their HCP. Some described underestimating cardiac risks if treatment plans included lifestyle changes only or if discussions focused primarily on comorbidities. Reflecting on time between diagnosis and an ASCVD event, many participants acknowledged they had not taken their care plan as seriously as they should have. Participants offered messages and suggestions for communicating effectively with others with high LDL-C at diagnosis and regularly after diagnosis (see Table 2).

Conclusions: Findings highlight an opportunity to improve cardiovascular care by overcoming indifference towards high LDL-C. Effective communication by healthcare providers at diagnosis and beyond, such as emphasizing the severity of high cholesterol and providing a realistic care plan, is crucial.
  • Johnson, Neil  ( Global Heart Hub , Galway , Ireland )
  • Kelly, David  ( Global Heart Hub , Galway , Ireland )
  • Oehrlein, Elisabeth  ( Applied Patient Experience , Washington , District of Columbia , United States )
  • Vandigo, Joe  ( Applied Patient Experience , Washington , District of Columbia , United States )
  • De Carvalho, Fernanda  ( Instituto Lado a Lado pela Vida , Sao Paulo , Brazil )
  • Gorre, Celina  ( WomenHeart , Washiton , District of Columbia , United States )
  • Hall, Tanya  ( hearts4heart , Melbourne , Victoria , Australia )
  • Hennessy, Susan  ( UCSF , San Francisco , California , United States )
  • Kazi, Dhruv  ( BIDMC , Boston , Massachusetts , United States )
  • Kotseva, Kornelia  ( National Institute for Prevention and Cardiovascular Health, National University of Ireland – Galway , Galway , Ireland )
  • Petrie, Patsy  ( HEART UK & FH Europe Foundation Ambassador , Linlithgow , United Kingdom )
  • Author Disclosures:
    Neil Johnson: DO NOT have relevant financial relationships | David Kelly: DO NOT have relevant financial relationships | Elisabeth Oehrlein: DO have relevant financial relationships ; Employee:Applied Patient Experience, LLC:Active (exists now) ; Consultant:National Pharmaceutical Council:Active (exists now) ; Consultant:PhRMA:Active (exists now) ; Consultant:Jazz Pharmaceuticals:Active (exists now) ; Consultant:BioMarin:Active (exists now) ; Consultant:AstraZeneca:Active (exists now) ; Advisor:Sanofi:Active (exists now) ; Consultant:Novartis:Active (exists now) | Joe Vandigo: DO have relevant financial relationships ; Employee:Novartis:Past (completed) ; Individual Stocks/Stock Options:Novartis:Active (exists now) ; Consultant:PhRMA:Active (exists now) | Fernanda De Carvalho: No Answer | Celina Gorre: DO have relevant financial relationships ; Advisor:BMS:Past (completed) ; Speaker:Eli Lilly:Expected (by end of conference) ; Speaker:Amgen:Past (completed) ; Speaker:Medtronic:Past (completed) | Tanya Hall: DO NOT have relevant financial relationships | Susan Hennessy: DO NOT have relevant financial relationships | Dhruv Kazi: DO NOT have relevant financial relationships | Kornelia Kotseva: DO NOT have relevant financial relationships | Patsy Petrie: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Challenges and Complexities in Patient and Caregiver Support in Rural Communities

Sunday, 11/17/2024 , 03:15PM - 04:30PM

Moderated Digital Poster Session

More abstracts on this topic:
Abdominal Circumference and Coronary Calcium Score in a Healthy Nonobese Brazilian Cohort: ELSA-Brasil Cohort Analysis

Correa Fabiano Ronaldo, Bittencourt Marcio, Bosco Mendes Thiago, Romero-nunez Carlos, Generoso Giuliano, Staniak Henrique, Foppa Murilo, Santos Raul, Lotufo Paulo, Bensenor Isabela

Canonical And Noncanonical Heat Shock Factor 1 Signaling In Smooth Muscle Cells Promote Atherosclerotic Plaque Burden

Chattopadhyay Abhijnan, Morse Andrew, Guan Pujun, Majumder Suravi, Kwartler Callie, Milewicz Dianna

More abstracts from these authors:
Limitations of the Generalizability of Semaglutide Trials Evaluating CV Outcomes

Shi Ivy, Yeh Robert, Khan Sadiya, Ndumele Chiadi, Hennessy Susan, Penko Joanne, Kazi Dhruv

Closing

Kazi Dhruv

You have to be authorized to contact abstract author. Please, Login
Not Available